Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|December 23, 2014
Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control studyJacopo Lenzi, Paola Rucci, Ilaria Castaldini, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 6, 2016
The Effect of Age on Characteristics and Mortality of Intracerebral Hemorrhage in the Oldest-OldPaola Forti, Fabiola Maioli, Michele Domenico Spampinato, et al.
Experimental Gerontology|March 23, 2002
Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly populationGiovanni Ravaglia, Paola Forti, Fabiola Maioli, et al.
Clinical Interventions in Aging|November 2, 2023
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 "Anti-Aging" Food Supplements in Healthy Older Adults)Antonio Muscari, Paola Forti, Mara Brizi, et al.
Ultrasound in Medicine & Biology|June 14, 2017
Accuracy of Lung Ultrasound in Patients with Acute Dyspnea: The Influence of Age, Multimorbidity and Cognitive and Motor ImpairmentLuca Vizioli, Paola Forti, Elena Bartoli, et al.
Age and Ageing|June 25, 2026
Geriatric team support in the emergency department-a randomised trial investigating the effects on hospital admission and community care in older adults (GerED-21)Maria L Lunardelli, Dino Gibertoni, Alessandra Colantoni, et al.
Geroscience|September 8, 2025
The proBNPage reduction (PBAR) trial-results of a randomized, double blind, placebo-controlled, pilot study to fine tune an NT-proBNP-based method to assess the effect of anti-aging treatmentsAntonio Muscari, Paola Forti, Donatella Magalotti, et al.
International Journal of Legal Medicine|July 19, 2020
Medico-legal assessment of personal damage in older people: report from a multidisciplinary consensus conferenceFrancesca Ingravallo, Ilaria Cerquetti, Luca Vignatelli, et al.
Neurobiology of Aging|January 12, 2011
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationsJean-Charles Lambert, Diana Zelenika, Mikko Hiltunen, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Pageof 8